Food Allergy

Allergy-related ED visits increased 14% in the United States between 2007 and 2015, researchers wrote in The Journal of Allergy and Clinical Immunology: In Practice.

A food allergy free diet may effectively improve histologic, molecular, endoscopic and symptomatic disease activity in adult patients with eosinophilic gastritis/gastroenteritis, according to data from Digestive Disease Week.

Researchers have developed an at-home anaphylaxis management algorithm for patients who need emergency epinephrine treatment. Importantly, it may prevent unnecessary ED visits — a particularly helpful development given the risk that COVID-19 poses in health care settings.

The FDA issued an alert about EpiPen 0.3 mg auto-injectors, EpiPen Jr. 0.15 mg auto-injectors and authorized generic versions, stating that these products may have delayed or incorrect injections that could cause injury or death.

Although there have been improvements over the years, racial, socioeconomic and ethnic disparities in food allergy are still prevalent in the United States, according to a presentation at the American College of Asthma, Allergy & Immunology Scientific Meeting.

HOUSTON — Not all children and teenagers will embrace maintenance food allergy treatments, such as the Viaskin Peanut epicutaneous patch or the biologic oral immunotherapy for peanut allergy known as AR101 — both of which are investigational therapies — according to a speaker at the American College of Allergy, Asthma and Immunology Annual Scientific Meeting.

HOUSTON — Children who received the peanut patch saw improvements in their health-related quality of life, according to an analysis of the PEPITES and PEOPLE studies.

HOUSTON — Between 2006 to 2015, the number of children aged younger than 3 years who visited the ED for anaphylaxis increased, but the number of subsequent hospitalizations decreased, according to findings presented at the American College of Asthma, Allergy & Immunology Scientific Meeting.

HOUSTON — Women who are pregnant, and their spouses, or those who have recently become new parents, are likely to have many questions about asthma and food allergy, according to a panel at the American College of Allergy, Asthma and Immunology Annual Scientific Meeting.

The FDA’s Allergenic Products Advisory Committee recently voted in support of AR101, an investigational biologic oral immunotherapy for peanut allergy in children and teenagers, bringing it one step closer to approval.